findmyKOL

Lakshmi Durairaj, MD

Basic profile

University of Iowa Hospitals and Clinics

ORCIDNPI
RegionIowa City, IA · MidwestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2005–2012Why? →

Lakshmi Durairaj is a Respiratory physician affiliated with University of Iowa Hospitals and Clinics. OpenAlex indexes 28 publications with 1,332 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,332citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
3NIH grants · 2005–2012

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 Hawkins Dr
Iowa City, IA 522421009

Telephone

319-353-7968

Registry record last updated 29 Nov 2007.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    57.7%
    Kinase inhibitor31%
    Ofev100%
    Part D13 patients
    Pyridone11.6%
    Pirfenidone100%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    16.5%
    Corticosteroid8.5%
    Prednisone100%
    Part D<11 patients
    Antidiarrheal microorganisms4.2%
    Folic Acid100%
    Part D<11 patients

    + 1 more class in this area

  • Respiratory

    13%
    beta2-Adrenergic Agonist9.2%
    Albuterol Sulfate Hfa100%
    Part D<11 patients
    Corticosteroid3.9%
    Fluticasone Propionate100%
    Part D<11 patients
Where care is delivered (Part B)51.1% facility · 48.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 20052012 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”